Asian Spectator

Men's Weekly

.

G-NiiB Oral Microbiome Immunity Formula SIM01 Alleviates Post-COVID-19 Conditions

Clinical Study Published in the Prestigious International Medical Journal The Lancet Infectious Diseases

HONG KONG SAR - Media OutReach Newswire - 8 December 2023 - Hong Kong's leading biomedical and microbiome technology company, G-NiiB GenieBiome, is pleased to announce that a ground-breaking large-scale randomised, double-blind, placebo-controlled clinical trial ("the Trial") conducted on the efficacy of SIM01, an oral microbiome immunity formula developed by a top-notch medical school in Hong Kong, involving 463 patients who had contracted COVID-19, has strongly proved that the consumption of SIM01, an oral microencapsulated live bacteria formula, could significantly improve the gut microbiota after six months and lead to remarkable alleviation of post-COVID-19 sequelae ("long COVID"), encompassing a range of symptoms affecting different systems and organs.

Magazine

Berkah tambahan redenominasi: Ajang bersih-bersih transaksi korupsi dan pencucian uang

● Wacana redenominasi kembali muncul tahun ini.● Redenominasi bisa jadi sarana bersih-bersih transaksi negatif jumbo.● Perlu sosialisasi dan persiapan matang agar tidak menimbulkan k...

Bahaya hujan mikroplastik: Apa yang perlu masyarakat waspadai?

EL_JUSUF/Pexels, CC BYSelama ini, kita mungkin mengira air hujan selalu menyegarkan. Namun, riset terbaru dari Badan Riset dan Inovasi Nasional (BRIN) menggugurkan asumsi itu. Berdasarkan studi yang d...

‘Father hunger’ lebih mengganggu perkembangan emosional anak dibandingkan ‘Fatherless’

Ilustrasi seorang ayah sedang mengajarkan anak perempuannya mengendarai sepeda.maxim ibragimov/Shutterstock● ‘Father hunger’ terjadi ketika anak hidup bersama ayah, tetapi kurang men...